ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Anti-Infective Medications Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12D10147
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global OTC Anti Infective Medications Market Insights Forecast to 2028
BUY CHAPTERS

Global OTC Anti-Infective Medications Market Research Report 2025

Code: QYRE-Auto-12D10147
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Novartis
Abbott
Sanofi
Bristol–Myers Squibb
Roche
NanoViricides
NovaBay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma

OTC Anti-Infective Medications Market Size

The global market for OTC Anti-Infective Medications was valued at US$ 94710 million in the year 2024 and is projected to reach a revised size of US$ 133500 million by 2031, growing at a CAGR of 5.1% during the forecast period.

OTC Anti-Infective Medications Market

OTC Anti-Infective Medications Market

OTC anti-infective medications are over-the-counter (OTC) drugs that are used to treat infections. These medications are commonly used to treat a wide range of infections, including respiratory, urinary tract, and skin infections.
OTC anti-infective medications include antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are used to treat bacterial infections, while antivirals are used to treat viral infections. Antifungals are used to treat fungal infections, and antiparasitics are used to treat parasite infections.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Medications.
The OTC Anti-Infective Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Anti-Infective Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of OTC Anti-Infective Medications Market Report

Report Metric Details
Report Name OTC Anti-Infective Medications Market
Accounted market size in year US$ 94710 million
Forecasted market size in 2031 US$ 133500 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital Pharmacies
  • Drug Stores
  • E-Commerce
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche, NanoViricides, Novabay Pharmaceuticals, Optimer Pharmaceuticals, Basilea Pharmaceutica, MerLion Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of OTC Anti-Infective Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is OTC Anti-Infective Medications Market growing?

Ans: The OTC Anti-Infective Medications Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the OTC Anti-Infective Medications Market size in 2031?

Ans: The OTC Anti-Infective Medications Market size in 2031 will be US$ 133500 million.

Who are the main players in the OTC Anti-Infective Medications Market report?

Ans: The main players in the OTC Anti-Infective Medications Market are GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche, NanoViricides, Novabay Pharmaceuticals, Optimer Pharmaceuticals, Basilea Pharmaceutica, MerLion Pharma

What are the Application segmentation covered in the OTC Anti-Infective Medications Market report?

Ans: The Applications covered in the OTC Anti-Infective Medications Market report are Hospital Pharmacies, Drug Stores, E-Commerce

What are the Type segmentation covered in the OTC Anti-Infective Medications Market report?

Ans: The Types covered in the OTC Anti-Infective Medications Market report are Antifungals, Antiseptic, Antiparasitics

Recommended Reports

Anti-Infective Medications

Infection Diagnostics

Fungal & Antiparasitic Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medications Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Medications Market Perspective (2020-2031)
2.2 Global OTC Anti-Infective Medications Growth Trends by Region
2.2.1 Global OTC Anti-Infective Medications Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2020-2025)
2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2026-2031)
2.3 OTC Anti-Infective Medications Market Dynamics
2.3.1 OTC Anti-Infective Medications Industry Trends
2.3.2 OTC Anti-Infective Medications Market Drivers
2.3.3 OTC Anti-Infective Medications Market Challenges
2.3.4 OTC Anti-Infective Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Medications Players by Revenue
3.1.1 Global Top OTC Anti-Infective Medications Players by Revenue (2020-2025)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2020-2025)
3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Anti-Infective Medications Revenue
3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2024
3.5 Global Key Players of OTC Anti-Infective Medications Head office and Area Served
3.6 Global Key Players of OTC Anti-Infective Medications, Product and Application
3.7 Global Key Players of OTC Anti-Infective Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medications Breakdown Data by Type
4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2020-2025)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2026-2031)
5 OTC Anti-Infective Medications Breakdown Data by Application
5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2020-2025)
5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Anti-Infective Medications Market Size (2020-2031)
6.2 North America OTC Anti-Infective Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Anti-Infective Medications Market Size by Country (2020-2025)
6.4 North America OTC Anti-Infective Medications Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medications Market Size (2020-2031)
7.2 Europe OTC Anti-Infective Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Anti-Infective Medications Market Size by Country (2020-2025)
7.4 Europe OTC Anti-Infective Medications Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medications Market Size (2020-2031)
8.2 Asia-Pacific OTC Anti-Infective Medications Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Medications Market Size (2020-2031)
9.2 Latin America OTC Anti-Infective Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Anti-Infective Medications Market Size by Country (2020-2025)
9.4 Latin America OTC Anti-Infective Medications Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medications Market Size (2020-2031)
10.2 Middle East & Africa OTC Anti-Infective Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medications Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medications Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medications Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medications Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medications Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medications Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.8.5 Roche Recent Development
11.9 NanoViricides
11.9.1 NanoViricides Company Details
11.9.2 NanoViricides Business Overview
11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.9.5 NanoViricides Recent Development
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Details
11.10.2 Novabay Pharmaceuticals Business Overview
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.10.5 Novabay Pharmaceuticals Recent Development
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Details
11.11.2 Optimer Pharmaceuticals Business Overview
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.11.5 Optimer Pharmaceuticals Recent Development
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Details
11.12.2 Basilea Pharmaceutica Business Overview
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.12.5 Basilea Pharmaceutica Recent Development
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Details
11.13.2 MerLion Pharma Business Overview
11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2020-2025)
11.13.5 MerLion Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Novartis
Abbott
Sanofi
Bristol–Myers Squibb
Roche
NanoViricides
NovaBay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
List of Tables
 Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antifungals
 Table 3. Key Players of Antiseptic
 Table 4. Key Players of Antiparasitics
 Table 5. Global OTC Anti-Infective Medications Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global OTC Anti-Infective Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global OTC Anti-Infective Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global OTC Anti-Infective Medications Market Share by Region (2020-2025)
 Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global OTC Anti-Infective Medications Market Share by Region (2026-2031)
 Table 11. OTC Anti-Infective Medications Market Trends
 Table 12. OTC Anti-Infective Medications Market Drivers
 Table 13. OTC Anti-Infective Medications Market Challenges
 Table 14. OTC Anti-Infective Medications Market Restraints
 Table 15. Global OTC Anti-Infective Medications Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global OTC Anti-Infective Medications Market Share by Players (2020-2025)
 Table 17. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2024)
 Table 18. Ranking of Global Top OTC Anti-Infective Medications Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of OTC Anti-Infective Medications, Headquarters and Area Served
 Table 21. Global Key Players of OTC Anti-Infective Medications, Product and Application
 Table 22. Global Key Players of OTC Anti-Infective Medications, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global OTC Anti-Infective Medications Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2020-2025)
 Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2026-2031)
 Table 28. Global OTC Anti-Infective Medications Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global OTC Anti-Infective Medications Revenue Market Share by Application (2020-2025)
 Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global OTC Anti-Infective Medications Revenue Market Share by Application (2026-2031)
 Table 32. North America OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America OTC Anti-Infective Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America OTC Anti-Infective Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe OTC Anti-Infective Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe OTC Anti-Infective Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific OTC Anti-Infective Medications Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America OTC Anti-Infective Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America OTC Anti-Infective Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 47. GlaxoSmithKline Company Details
 Table 48. GlaxoSmithKline Business Overview
 Table 49. GlaxoSmithKline OTC Anti-Infective Medications Product
 Table 50. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 51. GlaxoSmithKline Recent Development
 Table 52. Merck Company Details
 Table 53. Merck Business Overview
 Table 54. Merck OTC Anti-Infective Medications Product
 Table 55. Merck Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 56. Merck Recent Development
 Table 57. Pfizer Company Details
 Table 58. Pfizer Business Overview
 Table 59. Pfizer OTC Anti-Infective Medications Product
 Table 60. Pfizer Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 61. Pfizer Recent Development
 Table 62. Novartis Company Details
 Table 63. Novartis Business Overview
 Table 64. Novartis OTC Anti-Infective Medications Product
 Table 65. Novartis Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 66. Novartis Recent Development
 Table 67. Abbott Company Details
 Table 68. Abbott Business Overview
 Table 69. Abbott OTC Anti-Infective Medications Product
 Table 70. Abbott Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 71. Abbott Recent Development
 Table 72. Sanofi Company Details
 Table 73. Sanofi Business Overview
 Table 74. Sanofi OTC Anti-Infective Medications Product
 Table 75. Sanofi Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 76. Sanofi Recent Development
 Table 77. Bristol-Myers Squibb Company Details
 Table 78. Bristol-Myers Squibb Business Overview
 Table 79. Bristol-Myers Squibb OTC Anti-Infective Medications Product
 Table 80. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 81. Bristol-Myers Squibb Recent Development
 Table 82. Roche Company Details
 Table 83. Roche Business Overview
 Table 84. Roche OTC Anti-Infective Medications Product
 Table 85. Roche Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 86. Roche Recent Development
 Table 87. NanoViricides Company Details
 Table 88. NanoViricides Business Overview
 Table 89. NanoViricides OTC Anti-Infective Medications Product
 Table 90. NanoViricides Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 91. NanoViricides Recent Development
 Table 92. Novabay Pharmaceuticals Company Details
 Table 93. Novabay Pharmaceuticals Business Overview
 Table 94. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
 Table 95. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 96. Novabay Pharmaceuticals Recent Development
 Table 97. Optimer Pharmaceuticals Company Details
 Table 98. Optimer Pharmaceuticals Business Overview
 Table 99. Optimer Pharmaceuticals OTC Anti-Infective Medications Product
 Table 100. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 101. Optimer Pharmaceuticals Recent Development
 Table 102. Basilea Pharmaceutica Company Details
 Table 103. Basilea Pharmaceutica Business Overview
 Table 104. Basilea Pharmaceutica OTC Anti-Infective Medications Product
 Table 105. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 106. Basilea Pharmaceutica Recent Development
 Table 107. MerLion Pharma Company Details
 Table 108. MerLion Pharma Business Overview
 Table 109. MerLion Pharma OTC Anti-Infective Medications Product
 Table 110. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2020-2025) & (US$ Million)
 Table 111. MerLion Pharma Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. OTC Anti-Infective Medications Picture
 Figure 2. Global OTC Anti-Infective Medications Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC Anti-Infective Medications Market Share by Type: 2024 VS 2031
 Figure 4. Antifungals Features
 Figure 5. Antiseptic Features
 Figure 6. Antiparasitics Features
 Figure 7. Global OTC Anti-Infective Medications Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global OTC Anti-Infective Medications Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Pharmacies Case Studies
 Figure 10. Drug Stores Case Studies
 Figure 11. E-Commerce Case Studies
 Figure 12. OTC Anti-Infective Medications Report Years Considered
 Figure 13. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global OTC Anti-Infective Medications Market Share by Region: 2024 VS 2031
 Figure 16. Global OTC Anti-Infective Medications Market Share by Players in 2024
 Figure 17. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2024
 Figure 19. North America OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America OTC Anti-Infective Medications Market Share by Country (2020-2031)
 Figure 21. United States OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe OTC Anti-Infective Medications Market Share by Country (2020-2031)
 Figure 25. Germany OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific OTC Anti-Infective Medications Market Share by Region (2020-2031)
 Figure 33. China OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America OTC Anti-Infective Medications Market Share by Country (2020-2031)
 Figure 41. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2020-2031)
 Figure 45. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE OTC Anti-Infective Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 49. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 52. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 53. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 54. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 55. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 56. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 57. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 58. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 59. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 60. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global OTC Anti Infective Medicine Market Research Report 2025
OTC Anti Infective Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Anti Infective Products Market Research Report 2025
Global Anti infectives Medicine Market Research Report 2025
Anti Infective Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Anti Infective Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Anti Infectives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Infective Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Anti Infective Drugs Market Research Report 2025
Global Ophthalmic Anti infective Drug Market Research Report 2025
Global Pets Anti infectives Market Insights Forecast to 2030
Global Pets Anti Infective Medicine Market Insights Forecast to 2030
Global Livestock Anti Infective Medicine Market Insights Forecast to 2030
Global Animal Anti Infective Agents Market Research Report 2024
Global Animal Anti infectives Market Insights Forecast to 2030
Global Anti Infective Ophthalmic Market Insights Forecast to 2030
Global Animal Anti Infective Medicine Market Insights Forecast to 2030
Global Anti Infective Medications Market Research Report 2024
Ophthalmic Anti infective Preparations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Topical Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions